190 related articles for article (PubMed ID: 18285546)
21. Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.
Bora E; Soylar R; Arıkan-Ayyıldız Z; Uzuner N; Giray-Bozkaya Ö; Erçal D; Karaman Ö; Ülgenalp A
Allergol Immunopathol (Madr); 2013; 41(1):11-6. PubMed ID: 22361338
[TBL] [Abstract][Full Text] [Related]
22. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.
Balasa VV; Gruppo RA; Glueck CJ; Stroop D; Becker A; Pillow A; Wang P
Thromb Haemost; 1999 May; 81(5):739-44. PubMed ID: 10365747
[TBL] [Abstract][Full Text] [Related]
23. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
24. ALL and osteonecrosis.
Gaynon PS
Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
[TBL] [Abstract][Full Text] [Related]
25. [Osteonecroses of the bilateral tali during maintenance therapy in a child with acute lymphoblastic leukemia].
Nozaki H; Matsubara K; Mori S
Rinsho Ketsueki; 2006 Feb; 47(2):106-10. PubMed ID: 16529012
[TBL] [Abstract][Full Text] [Related]
26. Association of Plasminogen Activator Inhibitor-1 Gene Polymorphisms and Methylene Tetrahydrofolate Reductase Polymorphisms with Spontaneous Miscarriages.
Bubalo P; Buterin I; Šalek Z; Ðogić V; Zupančić-Šalek S
Acta Haematol; 2017; 138(2):111-115. PubMed ID: 28858863
[TBL] [Abstract][Full Text] [Related]
27. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
[TBL] [Abstract][Full Text] [Related]
29. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
Hizawa N; Maeda Y; Konno S; Fukui Y; Takahashi D; Nishimura M
Clin Exp Allergy; 2006 Jul; 36(7):872-6. PubMed ID: 16839401
[TBL] [Abstract][Full Text] [Related]
31. Association between Five Common Plasminogen Activator Inhibitor-1 (
Oh J; An HJ; Kim JO; Jun HH; Kim WR; Kim EJ; Oh D; Kim JW; Kim NK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570732
[TBL] [Abstract][Full Text] [Related]
32. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
33. Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.
Finch ER; Janke LJ; Smith CA; Karol SE; Pei D; Cheng C; Kaste SC; Inaba H; Pui CH; Wolf J; Relling MV
Pediatr Blood Cancer; 2019 Jun; 66(6):e27669. PubMed ID: 30758124
[TBL] [Abstract][Full Text] [Related]
34. Osteonecrosis in children with acute lymphoblastic leukemia.
Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
[TBL] [Abstract][Full Text] [Related]
35. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients.
Ferrari P; Schroeder V; Anderson S; Kocovic L; Vogt B; Schiesser D; Marti HP; Ganz R; Frey FJ; Kohler HP
Transplantation; 2002 Oct; 74(8):1147-52. PubMed ID: 12438962
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
Ozbek OY; Ataç FB; Ogus E; Ozbek N
Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
[TBL] [Abstract][Full Text] [Related]
37. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
39. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
Zgheib NK; Akra-Ismail M; Aridi C; Mahfouz R; Abboud MR; Solh H; Muwakkit SA
Pharmacogenet Genomics; 2014 Aug; 24(8):387-96. PubMed ID: 25007187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
